##semicolon##
Bacterial meningitis, Streptococcus pneumoniae, Pathogenesis, Blood-brain barrier, Central nervous system, Neuroinflammation, Inflammation, Diagnosis, Treatment##submission.citations##
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010). Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews, 23(3), 467–492.
Bundy, L. M., Rajnik, M., & Noor, A. (2023, July 6). Neonatal meningitis. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK/30335297
Cantu, R. M., & Das, J. M. (2023, August 7). Viral meningitis. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK/31424801
Chacon-Cruz, E., Roberts, C., Rivas-Landeros, R. M., Lopatynsky-Reyes, E. Z., Almada-Salazar, L. A., & Alvelais-Palacios, J. A. (2019). Pediatric meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Group B Streptococcus in Tijuana, Mexico: Active/prospective surveillance, 2005–2018. Therapeutic Advances in Infectious Disease, 6, 2049936119832274.
Doran, K. S., & Banerjee, A. (2016). Streptococcus pneumoniae meningitis and the CNS barriers. Frontiers in Cellular and Infection Microbiology, 6, 45.
National Institute for Health and Care Excellence. (2024, March). Evidence review for antibiotics for bacterial meningitis caused by Group B streptococcus: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review E3. London, UK. https://www.ncbi.nlm.nih.gov/ pubmed/38829982
National Institute for Health and Care Excellence. (2024, March). Evidence review for antibiotics for bacterial meningitis caused by Neisseria meningitidis: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review E6. London, UK. https://www.ncbi.nlm.nih.gov/ pubmed/38829980
National Institute for Health and Care Excellence. (2024, March). Evidence review for antibiotics for bacterial meningitis caused by Listeria monocytogenes: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review E5. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/ 38829977
National Institute for Health and Care Excellence. (2024, March). Evidence review for corticosteroids for treatment of bacterial meningitis: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review G4. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38838177
National Institute for Health and Care Excellence. (2024, March). Evidence review for fluid restriction in bacterial meningitis: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review G1. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38838179
National Institute for Health and Care Excellence. (2024, March). Evidence review for intracranial pressure monitoring in bacterial meningitis: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review G3. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38838176
National Institute for Health and Care Excellence. (2024, March). Evidence review for investigating and diagnosing suspected bacterial meningitis with cerebrospinal fluid parameters: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review B3. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38843359
National Institute for Health and Care Excellence. (2024, March). Evidence review for investigating and diagnosing suspected bacterial meningitis with blood and urine investigations: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review B1. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38843364
National Institute for Health and Care Excellence. (2024, March). Evidence reviews for timing of antibiotics for bacterial meningitis: Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management: Evidence review C1. London, UK. https://www.ncbi.nlm.nih.gov/pubmed/38838180
Fuentes-Antras, J., Ramírez-Torres, M., Osorio-Martinez, E., Lorente, M., Lorenzo-Almoros, A., Lorenzo, O., & Górgolas, M. (2019). Community-acquired acute bacterial meningitis: Update on clinical features and prognostic factors. New Microbiologica, 41(4), 81–87.
Kim, K. S. (2010). Pathogenesis and pathophysiology of pneumococcal meningitis. Infection and Immunity, 78(2), 505–510.
Koening, K. L., & Albrecht, M. A. (2021). Advances in the pathogenesis and treatment of pneumococcal meningitis.
Le Turnier, P., Navas, D., Garot, D., Guimard, T., Bernard, L., Tattevin, P., Vandamme, Y. M., Xoff, J., Chiffoleau, A., Dary, M., Leclair-Visonneau, L., Gregoire, M., Pere, M., Boutoille, D., Sébille, V., Dailly, E., & Asseray, D. (2019). Tolerance of high-dose ceftriaxone in CNS infections: A prospective multicenter cohort study. Journal of Antimicrobial Chemotherapy, 74(4), 1078–1085.
Mańdziuk, J., & Kuchar, E. P. (2023, April 10). Streptococcal meningitis. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK/32119335
National Institute for Health and Care Excellence. (2024, March 19). Meningitis (bacterial) and meningococcal disease: Recognition, diagnosis and management. London, UK. https://www.ncbi.nlm.nih.gov/ pubmed/38843370
Mount, H. R., & Boyle, S. D. (2017, September 1). Aseptic and bacterial meningitis: Evaluation, treatment, and prevention. The Journal of the American Board of Family Medicine, 96(5), 314–322.
Wright, W. F., Pinto, C. N., Palisoc, K., & Baghli, S. (2019, March 15). Viral (aseptic) meningitis: A review. Journal of Neurological Sciences, 398, 176–183.
Runde, T. J., Anjum, F., & Hafner, J. W. (2023, August 8). Bacterial meningitis. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK/29261975
Yosh, N., & Tomas, M. (2018, November). Meningitis in adults: Diagnosis and management. Internal Medicine Journal, 48(11), 1294–1307.